| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |